IO Biotech
Latest round
- Series C
Last raised
- Oct 2021
Total raised
- $190M
Investors
- 16
About IO Biotech
Based in Copenhagen, Denmark and founded in 2015 by its CEO, Dr. Mai-Britt Zocca, and co-founders Anders Ljungqvist, Inge Svane, Mads Andersen, and Per Straten, IO Biotech ApS is a clinical-stage biotech company that develops novel therapeutic immuno-oncology vaccines for cancer treatment.1 million. IO Biotech ApS uses the T-win technology platform and develops IO102-IO103 designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1.
Who invested in IO Biotech
16 investors across 4 rounds
See all investors in IO Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IO Biotech
Who invested in IO Biotech?
IO Biotech has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IO Biotech raised?
IO Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did IO Biotech last raise money?
IO Biotech's most recent round on record is a Series C, in Oct 2021.
What does IO Biotech do?
Based in Copenhagen, Denmark and founded in 2015 by its CEO, Dr.
Where is IO Biotech headquartered?
IO Biotech is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like IO Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at IO Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like IO Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.